The Parasitic Worm Product ES‐62 Targets Myeloid Differentiation Factor 88–Dependent Effector Mechanisms to Suppress Antinuclear Antibody Production and Proteinuria in MRL/lpr Mice
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Objective: The hygiene hypothesis suggests that parasitic helminths (worms) protect against the development of autoimmune disease via a serendipitous side effect of worm‐derived immunomodulators that concomitantly promote parasite survival and limit host pathology. The aim of this study was to investigate whether ES‐62, a phosphorylcholine‐containing glycoprotein secreted by the filarial nematode Acanthocheilonema viteae, protects against kidney damage in an MRL/lpr mouse model of systemic lupus erythematosus (SLE). Methods: MRL/lpr mice progressively produce high levels of autoantibodies, and the resultant deposition of immune complexes drives kidney pathology. The effects of ES‐62 on disease progression were assessed by measurement of proteinuria, assessment of kidney histology, determination of antinuclear antibody (ANA) production and cytokine levels, and flow cytometric analysis of relevant cellular populations. Results: ES‐62 restored the disrupted balance between effector and regulatory B cells in MRL/lpr mice by inhibiting plasmablast differentiation, with a consequent reduction in ANA production and deposition of immune complexes and C3a in the kidneys. Moreover, by reducing interleukin‐22 production, ES‐62 may desensitize downstream effector mechanisms in the pathogenesis of kidney disease. Highlighting the therapeutic importance of resetting B cell responses, adoptive transfer of purified splenic B cells from ES‐62–treated MRL/lpr mice mimicked the protection afforded by the helminth product. Mechanistically, this reflects down‐regulation of myeloid differentiation factor 88 expression by B cells and also kidney cells, resulting in inhibition of pathogenic cross‐talk among Toll‐like receptor–, C3a‐, and immune complex–mediated effector mechanisms. Conclusion: This study provides the first demonstration of protection against kidney pathology by a parasitic worm–derived immunomodulator in a model of SLE and suggests therapeutic potential for drugs based on the mechanism of action of ES‐62.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Blair, P. A., Noreña, L. Y., Flores-Borja, F., Rawlings, D. J., Isenberg, D. A., Ehrenstein, M. R., & Mauri, C. (2010) · Immunity · doi:10.1016/j.immuni.2009.11.009 · Cited by 1,574
Targeting IL-17 and TH17 cells in chronic inflammation
Miossec, P., & Kolls, J. K. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3794 · Cited by 1,414 · cited 3×
“Studies in interleukin-23 (IL-23)– deficient mice suggest that the IL-23/IL-17 axis promotes such kidney inflammation (4), and, perhaps reflecting this, expanded populations of Th17- and IL-17– producing CD3 CD4 CD8 T cells are observed in the kidneys of both lupus-prone mice and patients with SLE (5).”
BackgroundDiversity and dialogue in immunity to helminths
Allen, J. E., & Maizels, R. M. (2011) · Nature reviews. Immunology · doi:10.1038/nri2992 · Cited by 831 · cited 2×
“Consistent with this notion, in experimental models of autoimmune disease, infection with helminths was shown to be protective (9,10), and this has generated interest in the potential for exploiting”
BackgroundResultDynamic regulatory network controlling TH17 cell differentiation
Yosef, N., Shalek, A. K., Gaublomme, J. T., Jin, H., Lee, Y., Awasthi, A., Wu, C., Karwacz, K., Xiao, S., Jorgolli, M., et al. (2013) · Nature · doi:10.1038/nature11981 · Cited by 682
Al-Riyami, L., Pineda, M. A., Rzepecka, J., Huggan, J. K., Khalaf, A. I., Suckling, C. J., Scott, F. J., Rodgers, D. T., Harnett, M. M., & Harnett, W. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm401251p · Cited by 94 · cited 4×
“Intracellular analysis involved staining with APC-conjugated anti–IL-6, APC-conjugated anti–IL-10 (BioLegend) (13), or anti-myeloid differentiation factor 88 (anti-MyD88) (Abcam) and fluorescein isothiocyanate (FITC)–conjugated goat antirabbit IgG (Vector) (14).”
MethodInfluentialSelf-citationPrado, C., de Paz, B., Gómez, J., López, P., Rodríguez-Carrio, J., & Suárez, A. (2011) · Rheumatology · doi:10.1093/rheumatology/ker227 · Cited by 33
Cited by
Doonan, J., Lumb, F. E., Pineda, M. A., Tarafdar, A., Crowe, J., Khan, A. M., Suckling, C. J., Harnett, M. M., & Harnett, W. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01016 · Cited by 38
Self-citationCorbet, M., Pineda, M. A., Yang, K., Tarafdar, A., McGrath, S., Nakagawa, R., Lumb, F. E., Suckling, C. J., Harnett, W., & Harnett, M. M. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1010069 · Cited by 22
Self-citationMini Review: Structure and Function of Nematode Phosphorylcholine-Containing Glycoconjugates
Buitrago, G., Duncombe-Moore, J., Harnett, M. M., & Harnett, W. (2021) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2021.769000 · Cited by 8
Self-citation
Metadata
- Authors
- Rodgers, D. T., McGrath, M. A., Pineda, M. A., Al‐Riyami, L., Rzepecka, J., Lumb, F., Harnett, W., & Harnett, M. M.
- Venue
- Arthritis & Rheumatology
- Publisher
- Wiley
- Published
- 2015-03-27
- Volume
- 67
- Issue
- 4
- Pages
- 1023-1035
- ISSN
- 2326-5191 (ISSN-L)
- 2326-5205
- OpenAlex
- W1598263310
- Cited by
- 55
- References
- 6
- FWCI
- 4.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.